Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Shares to be Issued
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   27,617,415      
Beginning balance at Dec. 31, 2024 $ 25,389 $ 276 $ 216,483   $ (191,370)
Issuances of common stock:          
Share-based compensation (in shares)   453,832      
Share-based compensation 1,908 $ 5 1,903    
Option exercises (cash and cashless) (in shares)   7,851      
Option exercises (cash and cashless) 21   21    
Payments for taxes related to net share settlement of equity awards (in shares)   (98,914)      
Payments for taxes related to net share settlement of equity awards (1,305) $ (1) (1,304)    
Net loss for the period (6,026)       (6,026)
Ending balance (in shares) at Mar. 31, 2025   27,980,184      
Ending balance at Mar. 31, 2025 $ 19,987 $ 280 217,103   (197,396)
Beginning balance (in shares) at Dec. 31, 2025 29,368,760 29,368,760      
Beginning balance at Dec. 31, 2025 $ 28,020 $ 294 238,995 $ 5,641 (216,910)
Issuances of common stock:          
Share-based compensation (in shares)   748,681      
Share-based compensation 2,218 $ 7 2,211    
Option exercises (cash and cashless) (in shares)   47,292      
Option exercises (cash and cashless) 148 $ 1 147    
Acquisition of IRRAS (in shares)   7,885      
Acquisition of IRRAS     106 (106)  
Payments for taxes related to net share settlement of equity awards (in shares)   (185,979)      
Payments for taxes related to net share settlement of equity awards (1,993) $ (2) (1,991)    
Net loss for the period $ (9,552)       (9,552)
Ending balance (in shares) at Mar. 31, 2026 29,986,639 29,986,639      
Ending balance at Mar. 31, 2026 $ 18,841 $ 300 $ 239,468 $ 5,535 $ (226,462)